Case report reveals incidental myocardial uptake of 68Ga-NODAGA-JR11 in neuroendocrine tumor, implying need for careful interpretation.
68 Ga-labeled somatostatin receptor (SSTR) antagonists such as 68 Ga-NODAGA-JR11 are increasingly used for imaging neuroendocrine tumors (NETs) owing to their higher lesion detection rates compared with agonists. Incidental findings on these scans can occasionally provide unexpected insights. We report a patient with NET who demonstrated diffuse uptake of 68 Ga-NODAGA-JR11 in the left ventricular myocardium. This unusual finding raises considerations regarding non-tumor binding sites of SSTR antagonists and their potential physiological or pathologic correlates. Awareness of such uptake patterns is essential to avoid misinterpretation.
No takes yet. Share an insight, caveat, or question.
Taggar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: